Views & Analysis Patient power in Europe – more work to be done In the latest edition of Deep Dive: Patient centricity, pharmaphorum’s Andrew McConaghie talks to Kaisa Immonen, the co-chair of the Euro
News GSK boosts anti-infectives pipeline with Scynexis antifungal Last year, GSK said it was planning to invest a cool £1 billion in infectious d
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?